AmerisourceBergen 2011 Annual Report Download - page 22

(a) Includes $16.6 million of employee severance, litigation and other costs, net of income tax benefit of $7.0 million, an intangible asset impairment charge of $4.1 million, net of
income tax benefit of $2.4 million, and a $1.3 million gain from antitrust litigation settlements, net of income tax expense of $0.8 million.
(b) Includes a $2.7 million litigation gain, net of income tax expense of $1.7 million, intangible asset impairment charges of $2.0 million, net of income tax benefit of $1.2 million,
and a $12.8 million gain from antitrust litigation settlements, net of income tax expense of $7.9 million.
(c) Includes $3.4 million of employee severance, litigation and other costs, net of income tax benefit of $2.0 million, intangible asset impairment charges of $7.3 million, net of
income tax benefit of $4.5 million, and an influenza vaccine inventory write-down of $9.6 million, net of income tax benefit of $5.9 million.
(d) Includes $7.6 million of employee severance, litigation and other costs, net of income tax benefit of $4.8 million, a $2.1 million gain from antitrust litigation settlements, net of
income tax expense of $1.4 million, and an intangible asset impairment charge of $3.3 million, net of income tax benefit of $2.0 million. In fiscal 2008, the Company recorded
a non-cash charge to reduce the carrying value of PMSI by $224.9 million, net of income tax benefit of $0.9 million.This non-cash charge, which is reflected in discontinued
operations, reduced diluted earnings per share by $0.69.
(e) Includes $5.0 million of employee severance, litigation and other costs, net of income tax expense of $2.9 million and a $22.1 million gain from antitrust litigation settlements,
net of income tax expense of $13.7 million and also includes a $17.5 million charge relating to the write-down of tetanus-diphtheria vaccine inventory to its estimated net
realizable value, net of income tax benefit of $10.3 million.
As a result of the July 31, 2007 divestiture of Long-Term Care, the statement of operations data includes the operations of Long-Term Care for the ten months ended July 31,
2007 and the September 30, 2007 balance sheet data excludes Long-Term Care.
Selected Financial Data
The following table should be read in conjunction with the consolidated financial statements, including the notes thereto, and Management’s Discussion and
Analysis of Financial Condition and Results of Operations, available in the Company’s Annual Report on Form 10-K as filed with the SEC for the fiscal year
ended September 30, 2011. On June 15, 2009, the Company effected a two-for-one stock split of its outstanding shares of common stock in the form of a
100% stock dividend.All applicable share and per-share amounts were retroactively adjusted to reflect this stock split.
As of or for the fiscal year ended September 30,
(amounts in thousands, except per share amounts) 2011 (a) 2010 (b) 2009 (c) 2008 (d) 2007 (e)
Statement of Operations Data:
Revenue $80,217,558 $77,953,979 $71,759,990 $70,189,733 $65,672,072
Gross profit 2,539,096 2,356,642 2,100,075 2,047,002 2,219,059
Operating expenses 1,336,351 1,253,007 1,216,326 1,219,141 1,430,322
Operating income 1,202,745 1,103,635 883,749 827,861 788,737
Interest expense, net 76,721 72,494 58,307 64,496 32,244
Income from continuing operations 706,624 636,748 511,852 469,064 474,803
Net income 706,624 636,748 503,397 250,559 469,167
Earnings per share from continuing operations — diluted $ 2.54 $ 2.22 $ 1.69 $ 1.44 $ 1.26
Earnings per share — diluted $ 2.54 $ 2.22 $ 1.66 $ 0.77 $ 1.25
Cash dividends declared per common share $ 0.43 $ 0.32 $ 0.21 $ 0.15 $ 0.10
Weighted average common shares outstanding — diluted 277,717 287,246 302,754 324,920 375,772
Balance Sheet Data:
Cash and cash equivalents $ 1,825,990 $ 1,658,182 $ 1,009,368 $ 878,114 $ 640,204
Short-term investment securities available-for-sale ————467,419
Accounts receivable, net 3,837,203 3,827,484 3,916,509 3,480,267 3,415,772
Merchandise inventories 5,466,534 5,210,098 4,972,820 4,211,775 4,097,811
Property and equipment, net 772,916 711,712 619,238 552,159 493,647
Total assets 14,982,671 14,434,843 13,572,740 12,217,786 12,310,064
Accounts payable 9,202,115 8,833,285 8,517,162 7,326,580 6,964,594
Long-term debt, including current portion 1,364,952 1,343,580 1,178,001 1,189,131 1,227,553
Stockholders’ equity 2,866,858 2,954,297 2,716,469 2,710,045 3,099,720
Total liabilities and stockholders’ equity $14,982,671 $14,434,843 $13,572,740 $12,217,786 $12,310,064
20